Filing Details

Accession Number:
0001628280-24-027720
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-11 18:26:28
Reporting Period:
2024-06-07
Accepted Time:
2024-06-11 18:26:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610618 Cidara Therapeutics Inc. CDTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478831 Jeffrey Stein 6310 Nancy Ridge Drive, Ste 101
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-07 8,000 $13.21 24,580 No 4 P Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 57,884 Direct
Common Stock 2,100 Indirect By son
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.05 to $13.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  2. The number of securities reported herein have been adjusted to reflect the 1-for-20 reverse stock split effected by the Issuer on April 24, 2024.
  3. Includes 200 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2024.